Quick Answer

DNAUSDC gives you a continuous market on NeoSoul DNA after NeoTrade shipping, a mid-October multi-venue spot debut, and the DNA-first Believe Plan rewrite. Match the ticker to NeoSoul DNA / DNAUSDC—BNB `0xA991F61940095AEA0724ef54077223B048c5CF7b`, DE NEO AGENT. The trade is interesting because NeoSoul already has a real product loop, named capital, and a token job you can watch print after listing week. Open the market from edgeX home when you are ready.

https://x.com/edgeX_exchange/status/2112107200936284185

First, the Ticker: DNA Means NeoSoul

DNA is a crowded label. On this listing it means one thing only: NeoSoul’s token on BNB Chain.

Contract: `0xA991F61940095AEA0724ef54077223B048c5CF7b`. On-chain name: DE NEO AGENT. Symbol: DNA. Decimals: 18. CoinMarketCap UCID: 42524. Guides such as Phemex Academy repeat the same trader rule every crowded ticker teaches—match the contract before you size anything.

The edgeX market is DNAUSDC: NeoSoul DNA versus USDC collateral. That is the object. Not another DNA meme. Not NeoSoul equity. Not ownership of an agent.

What NeoSoul Is Building

Most AI demos stop at intelligence. Markets care about something harder: can an agent research, decide, act inside hard limits, and leave a record that can be scored?

NeoSoul is built for that conversion problem. The team names two gaps. The Learning Gap is that general model training rarely preserves a full economic decision history—sources, assumptions, market state, action, costs, outcome, and post-mortem. The Execution Gap is that value creation needs accounts, markets, tools, permissions, capital, latency, liquidity, and exception handling. Docs at a glance put the answer in one line: NeoSoul is building a capability-production system for economic agents, anchored by evoevo and NeoTrade.

That is a commercial bet, not a theater pitch. NeoSoul wants agents that can become trusted economic actors: measurable, controllable, and accountable, while humans remain the principals. NeoSoul does not custody funds, pool assets, act as a discretionary asset manager, share trading profits, or promise returns. The ambition is infrastructure for an agent economy—not a black-box fund wrapped in AI branding.

Two products carry the system. NeoTrade works the Execution Gap as a local-first trading-agent client. evoevo works the Learning Gap as a data-readiness and evaluation engine. Together they create a loop: evidence informs agents; agents operate inside user-defined constraints; outcomes return as data; that data improves the next round of models, skills, and product behavior. DNA is the token NeoSoul wants inside that economy.

How NeoTrade and evoevo Work

NeoTrade: controlled execution, not open-ended automation

NeoTrade is NeoSoul’s trading-agent client for macOS and Windows (neotrade.pro). You set the objective, capital, market scope, permissions, and risk bounds. The agent researches, forms judgments, places authorized orders, and leaves an observable record. Custody and mandate stay with you. NeoTrade’s own product language is blunt: intelligence proposes, controls authorize, execution acts, records prove.

That control surface is why the product feels built for markets. NeoTrade supports Copilot versus Auto approval modes, least-privilege permissions, behavioral logging, automatic pauses under anomalies, and a Kill Switch that can halt agents immediately. Credits for in-app usage are prepaid with USDT on BSC, and the payer address can be separated from the trading wallet—another reminder that NeoTrade is tooling, not pooled capital.

Live venues today are Paper, predict.fun, and Polymarket. Broader CEX, DEX, meme-coin, and U.S. equity coverage is still planned in product status. Starting in prediction markets is intentional: resolvable outcomes make agent track records easier to score. Paper is a simulated environment before real capital, not proof of live edge. NeoTrade launched August 17, 2026. Skill Builder arrived September 1, so a trader can describe an idea in natural language and save it as a reusable skill. Medium’s pre TGE build report also describes shadow runs: a new version can make live-market decisions without real money, and only graduate after better performance on separate data. Permission to learn and permission to spend are managed separately.

evoevo: turning outcomes into economic-decision data

evoevo is the evaluation and data-readiness engine. It organizes sources, events, judgments, outcomes, and post-mortems into economic-decision data that can support training, evaluation, and regression testing. Prediction markets are the first data environment because they connect public information, ex ante judgments, prices, resolution rules, and final outcomes in one loop.

That is the commercial heart of NeoSoul. An agent that can trade inside risk limits is useful. An agent whose decisions can be scored against resolved outcomes is far more useful, because builders can improve it and users can decide whether it deserves more capital. Bitget’s listing packaging, summarized by CoinGabbar, names the same two products and the same DNA jobs—payments, governance, and security staking.

Why the product loop matters for DNA

If NeoTrade fees, skill calls, and data usage settle in DNA, product adoption becomes a demand path. If evoevo helps produce agents people are willing to pay for, that path gets stronger. DNAUSDC is therefore cleaner than most AI tickers: it prices whether controlled execution and scored outcomes turn into DNA settlement after the first listing week.

What Shipping and Capital Show

NeoSoul did not arrive as a blank brochure.

NeoTrade shipped August 17, 2026. Skill Builder followed September 1. On August 20, NeoSoul announced an $11M Pre-A with named backers including MH Ventures, Amber Group, ArkStream Capital, 0G Foundation, Kirin Capital, CatcherVC, and New Oak International. That capital map does not prove token capture by itself. It does show a serious team with serious partners behind products already in users’ hands.

Spot distribution arrived mid-October. KuCoin and Bitget opened DNA/USDT on October 16, and coverage from TechFlow and ChainCatcher placed DNA across a wider multi-venue spot wave in the same window. An airdrop checker is live for eligibility screening. We listed DNAUSDC on October 19, 2026 after that sequence. In trading terms, that order matters: spot venues created the discovery tape first, and the perpetual now lets you stay with—or fade—that tape around the clock instead of waiting for the next listing headline.

The listing-week tape already answered a simpler question than “what is the exact mid”: did anyone care? CoinMarketCap’s October 19 snapshot showed roughly $58M of 24h volume against a ~$21M market-cap print, with circulating supply near 90M of a fixed 1B. That mix says discovery was hot relative to float—not that any single print is your entry. Phemex Academy also reconstructed a strong first-day main-pool move on BNB Chain. For DNAUSDC, the point is audience and turnover arrived before the perpetual, so continuous long/short expression is arriving into a live debate rather than a blank chart.

NeoSoul’s site also prints network counters such as TOTAL AGENT, INTAKE AMOUNT, and TOKEN SPEND. Medium’s pre-TGE post framed more than 4 million agents and more than 11 million predictions with paying and subscribing users. Read those as project-reported shipping color, not as audited TVL or revenue. They can support the “products are being used” side of the long case, but they should not outrank the firmer inputs: the product loop, the funding map, Believe Plan, and the spot-to-perp sequence.

What DNA Captures - and the Believe Plan Constraint

Utility

NeoSoul’s FAQ positions DNA as payment for agent services, skill usage, data calls, and platform fees; as governance participation; and as settlement between agents. DNA is not equity, not a profit claim, not a redemption right, and not a promise of returns. That clarity helps the token story. DNA is meant to be the operating currency of NeoSoul’s agent economy, not a costume claim on company ownership.

Believe Plan

The October 2026 Believe Plan is the near-term catalyst that makes DNA exciting beyond the listing itself. NeoSoul says it will buy DNA on the open market for payroll and partners rather than pay from locked treasury inventory. NeoTrade payments for agents, skills, and data are framed as DNA-only. Technical partners settling in DNA get a 20% discount. Team unlocks move to KPI gates: the cliff stays, automatic linear vesting is scrapped, and missing a KPI period means zero unlock for that period. Investor vesting remains as designed. Community KPI co-creation ran through October 19 18:00 UTC+8, with the finalized framework also dated October 19.

This is the kind of token design traders actually want to see. DNA is being written into day-to-day product settlement and into team unlock logic while the market is still discovering the ticker. If NeoTrade adoption rises and DNA-only payments stick, the demand story gets sharper every week.

Supply

Fixed supply is 1,000,000,000 DNA. CoinMarketCap’s circulating print near 90M (9%) frames an early float with room for product fee demand and Believe Plan execution to matter. Phemex’s contract read also described a fixed 1B supply with 18 decimals and no mint function / no owner role on the checked BNB contract - useful confirmation beside the CMC float print. DNAUSDC is leveraged exposure to that token: continuous expression of the NeoSoul DNA view, not spot custody and not an airdrop claim.

Why DNAUSDC Is Worth Trading Now

A shipped capability stack, not a brochure

Most AI-agent names ask you to price a deck. NeoSoul already has dated shipping, named capital, live products on both sides of the Learning Gap and Execution Gap, and a mid-October spot wave. That is scarce enough in the agent-economy category to support a continuous market. DNAUSDC is how you express whether those marks keep compounding into DNA demand.

When the long case is strongest

Go long when the commercial proofs keep landing after listing week. NeoTrade and Skill Builder usage rises. DNA settlement shows up in actual product payments rather than announcement language. Partner DNA discounts and open-market payroll buys appear publicly. KPI-gated unlocks hold. Planned venues going live would strengthen the path further, because it widens where controlled agents can earn fees.

In that scenario, DNA starts pricing as an operating currency with follow-through, not just a listing-week attention spike. The long is a bet that product demand replaces launch heat.

When the short case is cleaner

Go short when the narrative stays hot while the proofs stay thin. Usage stalls. DNA settlement does not become habitual. Unlock gates soften or slip. Early multi-venue attention fades before fee demand replaces it, and the tape starts treating DNA as generic AI beta.

Match the NeoSoul contract before sizing any DNA label, and do not price planned venue expansion as if it is already live. Weak follow-through is a fadeable object. DNAUSDC lets you express that fade without waiting for the next spot headline.

Why both sides belong on a perpetual

The useful signals here print across days and weeks, not in a single blog post. A perpetual lets you stay long when proofs compound, flip short when they stall, or resize as the evidence changes. That is why DNAUSDC is live on edgeX: so both sides of the NeoSoul DNA debate can trade continuously while the post-listing tape is still forming.

Trade DNAUSDC Perpetuals on edgeX

Once the long/short map is clear, you need a market that stays open with the story. That is why we listed DNAUSDC: so you can stay long, flip short, or resize around the clock without waiting on the next spot headline.

On edgeX, you keep self-custody and authorize every fund movement yourself. We give you an order-book experience with no KYC onboarding, deep liquidity, high-speed matching, and transparent on-chain settlement - backed by Ethereum-settled infrastructure, audited contracts, and private-key control - so you can focus on the NeoSoul thesis instead of fighting venue friction.

Eligible volume can also progress Mystery Box: unlock boxes through eligible volume or tasks, then open for USDC rewards, fee cashback vouchers, points, and other prizes under the live campaign rules on that page. It is an optional rewards layer on the same DNAUSDC flow.

Frequently Asked Questions

What is NeoSoul?

NeoSoul builds AI agent economy infrastructure—a capability-production system anchored by NeoTrade for controlled local-first agent trading and evoevo for outcome evaluation. Start at neosoul.ai.

Which DNA is this?

NeoSoul DNA on BNB Chain: contract `0xA991F61940095AEA0724ef54077223B048c5CF7b`, on-chain name DE NEO AGENT, CMC UCID 42524.

What products are live today?

NeoTrade is live on macOS and Windows with venues on Paper, predict.fun, and Polymarket. evoevo is live as the evaluation / data-readiness surface. Broader CEX, DEX, and U.S. equity coverage is still planned.

What is DNA for?

Payment for agents, skills, data, and fees; governance; and settlement between agents. See the FAQ.

Why is DNAUSDC worth trading now?

Because NeoSoul has shipped NeoTrade and Skill Builder, raised $11M with named backers, published Believe Plan, and reached a mid-October multi-exchange spot wave—and DNAUSDC lets you express long or short continuously on edgeX.

What are the DNAUSDC market parameters?

Cross margin; up to 10x; tick $0.0001; step 0.1 DNA; minimum order 450 DNA; taker 0.0450% / maker 0.0400%; liquidation fee 1.00%. Check the DNAUSDC page for live specs.

Does trading DNAUSDC mean I own NeoSoul agents or airdrop rights?

No. DNAUSDC is a perpetual on NeoSoul DNA. It does not confer agent ownership, spot custody, equity, profit claims, or airdrop entitlement.